Bpifrance Financement S.A. is a French financial institution that provides a range of financing solutions and support services aimed at fostering the growth of startups, small and medium-sized enterprises (SMEs), and mid-cap companies. It offers various financial products, including medium to long-term loans, export insurance, and leasing options for both tangible and intangible assets. Additionally, Bpifrance supports companies through consulting services, guarantees for bank financing, and training for executives. The organization also engages in direct investments and manages funds aimed at enhancing the financial landscape for businesses at different stages of their development. Established in 1980 and based in Maisons-Alfort, France, Bpifrance was formerly known as OSEO S.A. and rebranded in July 2013. It operates as a subsidiary of Bpifrance SA, reinforcing its commitment to bolstering the French economy through diversified financial solutions.

Kreaxi is a private equity firm based in Paris, established in 2016, that focuses on investing in early-stage technology startups with high growth potential. With over 30 years of experience in the management and investment sector, Kreaxi is dedicated to supporting innovative companies as they develop and scale. The firm's investment strategy centers on identifying and nurturing startups that demonstrate significant promise in their respective fields, providing them with the capital and resources necessary to achieve their business objectives.

Evolem is a private equity and venture capital firm based in Lyon, France, that focuses on seed and startup investments, growth capital, acquisitions, and leveraged buyouts. Established in 1997, it specializes in a diverse range of sectors including industrial goods, transportation, financial services, consumer products, and renewable energies, among others. Evolem primarily targets small and medium-sized enterprises in France, particularly in the South-East and Île-de-France regions, with revenues ranging from €10 million to €100 million. The firm invests between €0.3 million and €3 million in startups and can commit up to €35 million in more established companies. It also considers co-investments and aims for both majority and minority stakes in its portfolio companies. Notably, Evolem operates as an evergreen fund, allowing for a flexible investment approach without external limited partners or exit deadlines.

Siparex Group is a private equity investment firm based in Lyon, France, founded in 1977. It specializes in investing in start-ups and mid-market companies across a diverse range of sectors, including software, manufacturing, e-commerce, life sciences, and healthcare services. Over its 30-year history, Siparex has established itself as a key player in the private equity landscape, expanding its operations internationally and becoming one of the independent leaders in the field. The firm manages several funds, including Siparex Entrepreneurs V and Siparex MidCap II, focusing on investments in companies with varying revenue profiles and enterprise values. Siparex aims to support the growth of its portfolio companies by providing not only capital but also strategic guidance.

Angelor SAS is a venture capital firm based in Lyon, France, established in 2007. The firm specializes in providing seed, early venture, and growth capital investments, primarily targeting sectors such as healthcare, medical devices, agrifood, social business, cleantech, robotics, and energy. Angelor also offers consulting services to assist private investors, known as business angels, in identifying investment opportunities, negotiating deals, and managing their portfolios. The firm focuses its investments in France, particularly in Lyon and the Île-de-France region, with typical investment amounts ranging from €0.05 million to €2 million. Angelor aims to support both novice and experienced investors, including private individuals and family offices, by facilitating direct investments in promising entrepreneurial ventures.

Ventech is a prominent venture capital firm founded in 1998 in France, specializing in early-stage investments across a diverse range of sectors, including both B2B and B2C markets in software and hardware. With a total asset management exceeding USD 1 billion, the firm operates multiple funds from its offices in Paris, Munich, and Shanghai, concentrating its investments primarily in Europe and Asia. Ventech's European focus includes regions such as France, the DACH area, and the Nordics, while its Chinese operations are managed through Ventech China, which emphasizes sectors like M-commerce, Big Data, and Fintech. The firm is committed to nurturing innovative startups, helping them to scale and achieve global leadership in their respective fields. Its portfolio features a variety of successful companies, demonstrating its extensive expertise and strategic approach to venture capital investment.

Seventure Partners is a Paris-based venture capital firm founded in 1997, specializing in investments in life sciences and information and communication technology. With offices in Munich, Geneva, London, and Basel, the firm manages approximately €660 million and focuses on identifying and nurturing innovative companies with high growth potential across North America, Europe, Asia-Pacific, the Middle East, and Africa. Seventure Partners engages closely with entrepreneurs, leveraging its expertise and extensive networks to support the development of emerging European leaders in their respective fields. The firm employs a team of over 20 professionals, including 15 investors, who possess significant knowledge in technology and private equity operations. Seventure’s investment strategy encompasses various sectors, including TMT, industrial, healthcare devices, and supply, with a typical investment range of €0.5 million to €2 million over a six-year horizon.

Crédit Agricole Régions Investissement SAS is a private equity and venture capital firm specializing seed, early venture, mid venture, emerging growth, middle market, mature and growth capital investments. It also specializes in industry consolidation, LBO, LBI, OBO, BIMBO and recapitalization transactions. It invests through common shares, preference shares, and convertible or redeemable shares. The firm prefers to invest in unlisted small and medium size companies and industries. It invests in all sectors, mainly in materials, production tools, services, distribution networks, research and development, trademarks and patents, recruiting, marketing and advertising services, commercial services and supplies, transportation, consumer services, healthcare providers and services, diversified financial services, software and services, and telecommunication services sectors. It seeks to invest in France with a focus on the former French region of Rhône-Alpes, Picardy, Alsace, Centre, Champagne-Ardenne, Limousin, Poitou-Charentes, Burgundy, Franche Comté and Lorraine, and its following former departments: Isère, Ain , Saône-et-Loire, Drôme, Ardèche, Loiret, Nièvre, Cher, Loire-et-Cher, Eure-et-Loire, Indre-et-Loire, Vienne, Indre, Haute Vienne. The firm invests between €0.15 million ($0.22 million) and €5 million ($5.62 million) per transaction in companies with revenues between €3 million ($4.40 million) and €200 million ($224.96 million). It seeks to take a minority stake up to 40 percent in its portfolio companies. Crédit Agricole Régions Investissement SAS is based in Lyon, France with additional offices in Reims, Dijon and Orléans, France.

Janngo is a venture capital firm based in Abidjan, Ivory Coast, with an additional office in Paris, France. The firm specializes in investing in small and medium enterprises across various stages, including seed, startup, early venture, mid venture, late venture, emerging growth, and growth capital. Janngo focuses on the digital ecosystem sector and aims to support pan-African digital champions with proven business models that deliver inclusive social impact. By providing business support and digital platforms, Janngo helps SMEs scale in high-growth sectors, fostering economic development and innovation across the continent.

Turenne Groupe operates as an independent private equity management company based in France, with offices in Paris, Lyon, Marseille, and Lille. Established in 1999, the firm focuses on investing in small and medium-sized enterprises (SMEs) that generate revenues between €5 million and €100 million. Turenne Groupe typically makes equity investments ranging from €1 million to €10 million, taking both minority and majority stakes in the businesses. The company supports entrepreneurs in their development and succession planning. With a team of 32 professionals, including 21 investors, Turenne Groupe manages and advises over €500 million in assets, sourced from institutional and individual investors. The firm primarily targets sectors such as consumer products and services, consumer durables, and business products and services.

123 Investment Managers is a venture capital and private equity firm based in Paris, France, with an additional office in Lyon. Established in 2000, the firm specializes in both direct investments in various stages of companies, from seed to mature firms, and fund of funds investments in venture capital and leveraged buyout funds. It focuses on sectors such as technology, industry, renewable energy, consumer goods, and health-related services, including accommodations like elderly homes and clinics. The firm typically invests between €0.8 million and €8 million in companies with enterprise values ranging from €5 million to €400 million, primarily targeting opportunities in Europe, particularly in France, Switzerland, the United States, and Canada. 123 Investment Managers may also co-invest alongside other funds.

Kompas is an early-stage investor in prop tech, construction tech, clean tech, industry 4.0 and enterprise software. Fund I ($160m) targets late Seed and Series A technology companies in Europe, Israel and the US. We back ambitious founders who develop technology to transform buildings into more sustainable and healthy spaces, reduce the environmental impact of the construction and manufacturing industries, and transform the way modern organisations work.

Demeter Partners is a private equity and venture capital firm based in Paris, France, specializing in investments that support the ecological transition. Founded in 2005, the firm focuses on seed, start-up, early-stage, growth, and infrastructure capital, investing between €0.5 million and €30 million in companies at various stages of development, including innovative startups and high-growth small to medium enterprises. Demeter primarily targets sectors such as eco-industries, green technology, renewable energy, and environmental services, with particular interest in energy efficiency and waste treatment. The firm predominantly operates in Europe, especially in France, but also invests in North America and other regions. Demeter Partners manages multiple private equity funds and prefers to take minority stakes, often seeking a board seat in its portfolio companies to assist in their development. In 2016, Demeter Partners merged with Emertec Gestion, enhancing its position as a leading player in the energy transition and environmental sectors.

Capitem Partners is an independent private equity firm focused on supporting small and medium-sized enterprises (SMEs) in France. Established by entrepreneurs, the firm aims to assist SME managers in equity operations and business development to help them achieve significant growth. Capitem Partners engages in a variety of investment strategies, including growth equity and buyouts, targeting profitable SMEs with revenues exceeding €5 million. The firm collaborates closely with efficient management teams, offering tailored solutions that align with the specific needs of the businesses they support. Through its involvement in development, build-ups, transmissions, spin-offs, and securities reclassification, Capitem Partners is dedicated to facilitating the advancement of companies under its stewardship.

Hi Inov SAS is a private investment firm based in Paris, France, with an additional office in Lyon. Founded in 2012, it specializes in early and mid-stage investments in technology companies within the digital economy, particularly focusing on areas such as point-of-sale (POS) systems and software as a service (SaaS). The firm targets investments in online services, social networks, mobile applications, digital media, and niche e-commerce. Hi Inov typically invests between €0.5 million and €4 million in companies that generate revenues between €0.5 million and €5.41 million. The firm aims to acquire a stake of 15% to 35% in its target companies and often seeks a board seat to guide their growth. With €165 million under management, Hi Inov is committed to supporting innovative B2B digital startups, helping them develop into future industry leaders.

Kennet V is a private equity growth expansion fund co-managed by Kennet Partners and Edmond de Rothschild Private Equity, established in 2020 and headquartered in London. The fund focuses on investing in companies within the information technology, software as a service (SaaS), business products and services, fintech, and healthcare technology sectors across the United States, Europe, and Asia. Kennet V aims to build a diversified portfolio of 10 to 15 investments, prioritizing opportunities that align with environmental, social, and governance (ESG) criteria. The firm is dedicated to providing growth capital to companies seeking to accelerate their development and enhance shareholder value, offering strategic support in areas such as business development, executive recruitment, and corporate finance initiatives. With a strong track record in the growth equity space, Kennet V seeks to partner with entrepreneurial technology businesses to facilitate their next phase of growth.

Garibaldi Capital Développement is the private equity arm of Banque Populaire Loire et Lyonnais. The firm specializes in direct, secondary (direct) and fund of fund investments. Within direct investments it specializes in buyouts, growth capital, mature, middle market, and mezzanine investments in small and medium size companies. The firm seeks to invest in information technology, electronics, industrial goods and services, other manufactured goods, transport buildings and public works. The firm prefers to invest in companies from all countries of Europe except Switzerland and in France with a focus on the former French region of Rhône-Alpes. It typically takes minority stake up to 40%. Garibaldi Capital Développement was founded in 2004 and is based in Lyon, France with and additional office in Saint Etienne, France.

Ardian, established in 1996 and led by Dominique Senequier, is an independent private investment company managing approximately $62 billion in assets across Europe, North America, and Asia. With a majority employee ownership structure, Ardian emphasizes entrepreneurship and aims to deliver strong investment performance to its global clientele while supporting economic growth. The company operates a diverse portfolio that includes funds of funds, private debt, direct investment strategies, infrastructure, and real estate, catering to a wide array of sectors such as transportation, energy, and technology. Ardian has a robust global presence, employing over 450 staff in twelve offices around the world, which enhances its investment capabilities and network. The firm serves around 580 investors by offering customized mandate solutions and a variety of investment strategies, including co-investment opportunities and funds targeting specific geographic regions and industries.

Mérieux Equity Partners is a management company based in Lyon, France, specializing in venture, growth, and leveraged buyout investments within the healthcare and nutrition sectors. Established in 2009, the firm focuses on supporting entrepreneurs and industrial companies that offer unique products and services. Mérieux Equity Partners leverages its extensive expertise and international network to provide strategic assistance to its portfolio companies. The firm manages over €600 million in assets under management and has recently initiated a new investment vehicle, MP3, with a target of €350 million, specifically aimed at growth and leveraged buyout opportunities.

XAnge is a venture capital investment firm based in Paris, founded in 2004, that specializes in seed and early-stage investments. With €450 million under management, XAnge focuses on digital, deeptech, and impact startups, aiming to support innovative technology entrepreneurs who address significant societal and environmental challenges. As the innovation brand of the Siparex group, a prominent player in French private equity, XAnge seeks to invest in game-changing startups across various sectors, including health, education, and sustainable housing. The firm is composed of a diverse team of five committed investors with expertise in technology and impact investing, dedicated to fostering solutions that have a meaningful impact in France and beyond.

Sofimac Régions SAS (formerly known as Sofimac Partners) is a private equity and venture capital firm specializing in incubation, seed, start-up, development, buy-in, distressed, early venture, growth capital, buyout, succession and turnaround transactions. It prefers to invest in small and medium-sized companies from all industries including industrial and services sectors, based in South-Eastern and Central France, more specifically in the French regions of Centre, Auvergne, Rhône-Alpes, Limousin and Provence Alpes Côte d´Azur. The firm usually invests between €0.05 million ($0.07 million) and €3 million ($4.18 million) in its portfolio companies and tends to hold its investments from eight to ten years. Sofimac Régions SAS was created in 1977 and is based in Clermont-Ferrand, France with additional offices in Limoges, France; Lyon, France; Roma, Italy; and Orléans, France. Sofimac Régions SAS operates as a subsidiary of Sofimac Investment Managers SAS.

Arkéa Capital, SAS, formerly known as Synergie Finance, is the private equity and venture capital arm of Crédit Mutuel Arkéa. It specializes in direct and fund of funds investments. Within direct investments, the firm makes seed, startup, early to late venture, growth capital, corporate restructuring, recapitalization and buyout investments in large-cap, mid-cap and small and medium size companies. It seeks to invest across all sectors with a focus on agriculture and fishing, food, consumer goods, industrial goods and services, biotechnology, communication, construction and public works, distribution, electronic, energy, computer hardware software, manufactures, healthcare, services, business services, financial services and transport and logistics. The firm prefers to invest in France with a focus on Western France and mainly in the former French Regions of Brittany, Pays-de-Loire, Basse-Normandie, Centre, Poitou-Charentes, Limousin and Aquitaine. As part of its seed and startup investment strategy, the firm usually makes equity investment between €0.1 million ($0.24 million) and €1 million ($1.18 million). As part of its growth capital, corporate restructuring and buyout strategy, the firm typically invests between €1 million ($1.09 million) and €70 million ($76.07 million) while seeking to make long-term investment. The firm typically exits its investments after five to ten years but can stay for more than ten years when it is a reference shareholder in large-cap companies. It prefers to take minority stakes in its portfolio companies and can co-invest. Arkéa Capital, SAS was founded in 1999 and is based in Le Relecq-Kerhuon, France with additional offices in Brest, Nantes, Paris, Rennes, Bordeaux, Lyon and Strasbourg.

5Y Capital is a private equity and venture capital firm based in Shanghai, China, specializing in seed, startup, early venture, and growth capital investments. Established in 1992, the firm focuses on a diverse range of sectors, including healthcare, technology, fintech, internet services, consumer services, media, and life sciences, among others. It aims to support entrepreneurs in building innovative companies, particularly in China and other emerging markets in Asia/Pacific. Managing approximately USD 5 billion in dual-currency funds, 5Y Capital attracts investments from global sources, including sovereign wealth funds and family offices. The firm typically makes initial investments exceeding USD 500,000 per portfolio company. 5Y Capital operates under the Morningside Group, which is committed to socially responsible investing, particularly in educational opportunities and scientific research.

MBO & Co, formerly known as MBO Partenaires, is a private equity firm established in 2002 and based in Paris, France, with additional offices in Lyon, Madrid, Shanghai, Bangalore, and Sao Paulo. The firm specializes in leveraged buy-outs, capital growth, and management buy-ins, focusing on small and medium-sized enterprises across various sectors in France, Spain, Belgium, Switzerland, and Luxembourg. MBO & Co typically invests between €1 million and €25 million in companies with enterprise values ranging from €5 million to €100 million and sales values from €5 million to €200 million. The firm aims to restructure shareholding and operational assets, facilitating management succession and financing development projects. With over one hundred transactions completed, MBO & Co positions itself as a committed partner to entrepreneurs, seeking to hold investments for an average of five years while pursuing majority or significant minority stakes. The firm has also enhanced its operational support for international business development and digital initiatives through tailored solutions.

Eurekap! is a venture capital firm established in 2010 and located in Lyon, France. The firm focuses on investing in young, innovative companies within the Rhone-Alpes region, aiming to support their growth through minority participation and co-investment strategies. Eurekap! has a business plan that outlines a capital raising goal of at least 800,000€ to finance startups. The founders expect to achieve a satisfactory return on capital within a timeframe of 6 to 8 years, highlighting their commitment to fostering innovation and entrepreneurship in their region.

Andera Partners, established in 2001 and previously known as Edmond de Rothschild Investment Partners, is a private equity firm based in Paris, France. The firm specializes in investing in unlisted companies across France and internationally, managing over €2 billion in assets. Its investment focus includes life sciences, growth capital, and sponsorless mezzanine debt. Andera Partners targets investments typically ranging from €10 million to €20 million, with a commitment to fostering long-term performance through autonomous, experienced teams that anticipate economic trends. The firm operates within a framework that emphasizes tailored solutions and a close relationship with its clients, reflecting the legacy and values of the Edmond de Rothschild Group, which has a long-standing reputation in European finance.

Blackfin Technology is a private equity and venture capital firm founded in 2008 and based in Paris, France, with additional offices in Frankfurt and Brussels. The firm specializes in investing in the financial services and technology sectors across Europe, targeting asset-light businesses in areas such as fintech, insurtech, regtech, and various financial services. Blackfin typically invests between €1 million and €30 million in companies with enterprise values of up to €100 million and revenues of up to €150 million. The firm aims to take a majority or influential minority stake in its portfolio companies, employing an active investment strategy that focuses on organic growth and operational improvements, as well as a buy-and-build approach. By supporting management teams, Blackfin seeks to enhance the performance and market reach of its investments, thereby driving significant value creation.

Elige Capital is a private equity firm founded in 2015, headquartered in Paris, France, with an additional office in Lyon. The firm specializes in growth capital investments in small and medium-sized enterprises across various sectors, primarily focusing on companies based in France and Switzerland. Elige Capital engages in different investment strategies, including leveraged buyouts, management buy-ins, management buyouts, and buy-in management buyouts. The firm typically invests between €0.5 million and €2.5 million in its portfolio companies, taking both majority and minority stakes, and also participates in co-investment opportunities.

ArchiMed SAS is a private equity firm established in 2014 and headquartered in Lyon, France, with an additional office in New York. The firm specializes in investing in small to mid-cap companies within the healthcare sector, focusing on areas such as care and wellness, medtech, biopharma, and public health. ArchiMed targets investments typically ranging from €5 million to €15 million, with the flexibility to invest between €2 million and €50 million or more, either alone or alongside co-investors. The firm seeks companies with revenues between €5 million and €100 million, though it can consider larger entities as well. ArchiMed primarily focuses on Western Europe, particularly France, the United Kingdom, and Switzerland, and it takes both minority and majority stakes, primarily in unlisted companies. The firm's funding sources include contributions from its team and investments from European and American institutional and private investors, including experienced healthcare entrepreneurs.

Bayer is a global life science company headquartered in Leverkusen, Germany, with operations spanning Pharmaceuticals, Consumer Health, Crop Science, and Animal Health. The Pharmaceuticals segment focuses on prescription products in cardiology and women’s health, along with specialty therapeutics for oncology and hematology. The Consumer Health division offers over-the-counter medicines, medical products, and self-care solutions across various categories. In the Crop Science segment, Bayer provides a range of agricultural products, including chemical and biological crop protection, seeds, and digital solutions. The Animal Health segment develops products for the prevention and treatment of diseases in both companion and farm animals. Bayer engages in collaborative research efforts to advance cancer treatments and identify new drug candidates for pulmonary diseases. With a commitment to innovation, the company has been active for over 120 years and operates numerous manufacturing and research facilities worldwide, contributing significantly to advancements in nutrition and healthcare.

Mérieux Développement is focused on growth and venture capital investments in the healthcare and nutrition sectors. The firm seeks to support companies with differentiated products or services that have substantial long-term value creation potential. With an investment team based in Europe and North America, Mérieux Développement leverages its expertise and extensive international network to assist entrepreneurs in capitalizing on significant market opportunities. It is an affiliate of Institut Mérieux, a global organization employing around 17,000 people and generating over 2.5 billion Euros in consolidated revenue as of 2017. Additionally, the firm manages a private equity growth expansion fund, Mérieux Participations 4, which primarily invests in Western Europe, targeting investments in the healthcare sector, particularly in health and nutrition, with a typical investment size ranging from 40 million to 45 million Euros.

Capital Export SAS is a private equity and venture capital firm specializing in seed, growth capital, mezzanine, secondary investments, succession, international expansion and buyout transactions. The firm seeks to invest in exporting companies or in companies in internationalization phase. It seeks to invest in small and medium sized companies in all industries including B2B, professionals services, industrials with a focus on e-business, engineering, and health. The firm prefers to invest in Europe with a focus on France. It typically invest between €2 million ($2.24 million) and €15 million ($16.79 million) in companies with revenues between €7 million ($7.83 million) and €100 million ($111.91 million). In addition, it invests in companies with international sales between 10 percent and 15 percent of the turnover. The firm makes investment in equity and quasi-equity. It also offers bank financing and assists its portfolio companies in obtaining aids and subsidies. The firm can makes co-investments. It prefers to take both minority and majority stakes. Capital Export SAS was founded in 2008 and is based in Paris, France with an additional office in Lyon, France.

ORAXYS S.A. is a private equity firm specializing in expansion capital investments for small and medium companies in the form of equity or quasi-equity i.e. shares and bonds. The firm seeks to invest in companies in sectors like environment, public health, energy, chemistry, food, water, health, electrical equipments, software, energy, materials, and clean technology. It makes equity investments in the range between €0.5 million ($0.69 million) and €4 million ($5.51 million) in companies with turnover upto €120 million ($165.41 million). ORAXYS S.A. is based at Luxemobourg with an additional office at Lyon, France.

2C Invest is a private equity and venture capital firm based in Lyon, France, founded in 2010. The firm focuses on providing growth capital to micro, small, and medium-sized companies across various industries, excluding real estate development, financial services, and agriculture. It primarily targets companies located in the former French region of Provence-Alpes-Côte-d'Azur and typically invests amounts ranging from €0.05 million to €0.15 million. 2C Invest is flexible in its investment approach, taking both minority and majority stakes and considering co-investments. The firm aims to exit its investments within a timeframe of five to seven years.

FIP iXO DEV 8 is a buyout fund managed by iXO Private Equity, an independent private equity management company based in Toulouse, France. Founded in 1981, iXO Private Equity specializes in investing in small and medium-sized enterprises (SMEs) throughout France. The firm operates under the oversight of the Financial Market Authorities and is recognized as the leading independent regional private equity General Partner in the country. FIP iXO DEV 8 is part of a broader portfolio that includes various private equity investment funds aimed at supporting the equity needs of high-potential companies in Western and Southern France. Through its focused investment strategy, the fund aims to contribute to the growth and development of its portfolio companies.

Crédit Agricole Centre-Est is a regional cooperative bank based in France, established in 1995. The organization offers a wide range of banking products and services tailored for individuals, professionals, associations, companies, and farmers. By focusing on local needs and community engagement, Crédit Agricole Centre-Est aims to support its clients in managing their financial affairs effectively.

Brick & Mortar Ventures is a venture capital firm established in 2015, located in San Francisco, California. The firm specializes in investing in architecture, engineering, construction, and technology sectors, particularly focusing on innovative software and hardware solutions for the built environment. By concentrating on the real estate, hospitality, and construction industries, Brick & Mortar Ventures cultivates deep industry expertise and fosters relationships that enhance the value of its portfolio companies. The firm takes an active role as an investor and partner, providing support to emerging companies that align with its mission of advancing technology for the built world. In 2022, Brick & Mortar Ventures launched an early-stage venture capital fund to further its investment activities.

Global Brain is a Tokyo-based venture capital firm founded in 1998, specializing in early-stage investments across various sectors, including e-commerce, software, gaming, media, IoT, education, entertainment, and fintech. The firm has expanded its investment activities to the US and Asia, targeting series A-stage technology companies. Since its inception, Global Brain has invested in approximately 30 companies, achieving seven initial public offerings and seven mergers and acquisitions. The firm supports its portfolio companies by providing not only capital but also strategic guidance, partnerships, and team-building resources to help them reach their milestones. Global Brain is particularly adept in e-commerce, operating a platform called EC-PLANET, which encompasses several group companies, including a large online sports goods store and a logistics firm offering comprehensive fulfillment services. This network, along with Global Brain's connections to established Japanese companies, facilitates market entry for US and Asian businesses into Japan.

A Plus Finance, which is headquartered in Paris (France), is an independent trust company specialising in the management of Common Investment Funds for Innovation (FCPI) and Proximity Investment Funds (FIP). A Plus Finance is involved in all innovative sectors, particularly in the IT, media and security fields. The A Plus Finance team includes financiers and entrepreneurs, thus providing companies with both an awareness of the daily constraints of management and a long-term perspective on the development of their business. Managing funds amounting to nearly €220m, A Plus Finance invests between €1 million and €4 million per project.per

Idinvest Partners is a private equity and venture capital firm based in Paris, France, primarily focused on the low and middle market segments in Europe. Founded in 1997, the firm manages over 6 billion euros and specializes in a variety of investment strategies, including equity investments in buyouts and growth capital for mid-sized and innovative companies. Idinvest also engages in fund of funds investments, targeting primary and secondary transactions in European private equity funds, along with mezzanine financing. The firm invests in multiple sectors, with particular emphasis on technology, digital, healthcare, and clean energy. Idinvest aims to support small and medium-sized enterprises, typically investing between 5 million to 40 million euros per deal. It has a history of successful investments in notable companies such as Criteo and Deezer. In 2019, Eurazeo acquired a majority stake in Idinvest Partners, enhancing its capabilities in private equity consulting and direct lending through various specialized funds.

Plug and Play, founded in 2006 and based in Sunnyvale, California, operates as a business accelerator and venture capital firm that focuses on early-stage and seed investments in technology startups. The firm runs 12 industry-specific accelerator programs annually, connecting startups with corporate partners and investors to foster collaboration and growth. Plug and Play's investment strategy encompasses a wide range of sectors, including fintech, health and wellness, travel, cybersecurity, and sustainability, allowing it to support diverse startups from any country. The firm provides various resources, including funding, mentorship, office space, and networking opportunities, and has a global presence with offices in North America, Europe, and Asia. Plug and Play has a strong track record, having helped numerous startups secure over $9 billion in funding since its inception. Its programs aim to refine business models and facilitate introductions to potential investors, ultimately contributing to the growth of the startup ecosystem.

Omnes Capital S.A.S. is a Paris-based venture capital and private equity firm that focuses on direct investments and fund of funds. It specializes in various investment stages, including seed, startup, and growth capital, primarily targeting small and mid-cap enterprises. The firm actively invests across a diverse range of sectors, such as information technology, life sciences, renewable energy, telecommunications, and agri-food, among others. Omnes Capital manages approximately €3.4 billion in assets and has a notable track record, including over 120 supported companies and 14 IPOs in its 16 years of operation. The firm seeks to take minority stakes in its portfolio companies and prefers a board seat to guide their growth. With a commitment to investing between €1 million and €50 million in companies with enterprise values up to €1 billion, Omnes Capital is recognized for its expertise in financing innovative SMEs, particularly in the technology and healthcare sectors. The firm was previously known as Credit Agricole Private Equity and operates additional offices in Brussels and Zurich.

Newfund Inc. is a venture capital firm established in 2008, with headquarters in Paris and additional offices in Massachusetts and San Francisco. Specializing in early-stage investments, Newfund manages a total of $300 million, focusing on pre-seed and seed funding primarily in France and North America. The firm targets innovative companies that contribute to global change, investing between €500,000 and €2 million in early-stage ventures. Newfund's investment strategy encompasses a range of sectors, including movies, entertainment, internet, media, business products and services, consumer products, energy, financial services, healthcare, information technology, and materials. With a commitment to nurturing growth, Newfund also provides follow-on investments as their portfolio companies develop.

BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions. The firm considers investments in manufacturing, service industries, medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors. BNP Paribas Développement was established in 1988 and is based in Paris, France.

Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow. We want to become the closest partner of our portfolio companies by working together on key strategic decisions and operative challenges. As a privately financed venture capital investor with long-term and flexible capital we are looking for exceptional founders who are committed to building category leaders throughout the next 5-10+ years. We invest in early-stage technology ventures with a focus on Real Estate, Finance & Insurance, Human Resources, Renewable Energy, Mobility, and Health. Picus makes initial investments in pre-seed, seed and series A ventures thereby starting to work together with entrepreneurs in various stages of their companies ranging from ideation phase to initial traction. We follow a very long-term investment approach investing significant amounts throughout the lifecycle of the companies. We have invested in over 50 companies to date. At Picus we work in a culture combining the discipline of a financial investor with the creativity and pragmatism of an entrepreneur. We follow a comprehensive and well-structured investment approach in order to identify the most attractive and ambitious investment opportunities in our target industries and geographies. Within our core investment team every member has a distinctive industry competence and a functional or geographic focus. We are working closely together with our portfolio companies to develop large and successful market leaders. This comprises in particular leveraging our marketing & sales expertise and our global market perspective to provide strategic advice, providing HR management to grant access to top talent, connecting our portfolio companies with our broad B2B & investor network as well as supporting the fundraising process.

Socadif SA, SCR is a private equity and venture capital firm affiliated with Caisse Régionale de Crédit Agricole Mutuel de Paris et d'Ile-de-France. Established in April 1990 and headquartered in Paris, France, Socadif specializes in late venture and growth capital investments, secondary investments, and management and leveraged buyouts, primarily focusing on small and medium enterprises. The firm invests in a range of sectors, including energy, metals and mining, construction and engineering, commercial services, hospitality, media, consumer staples, biotechnology, and information technology. Socadif typically targets investments between €1 million and €10 million in companies with revenues from €5 million to €200 million, often taking minority stakes of up to 40%. Its investment strategy is predominantly centered on the French market, particularly in the Île-de-France region.

Crédit Mutuel Equity is a private equity and venture capital firm based in France that focuses on supporting startups and companies across various stages of development, including seed, growth, and international expansion. The firm primarily invests in sectors such as information and telecommunication technology, healthcare, industrial innovations, electronics, life sciences, and new materials. With a preference for investments ranging from €0.5 million to €3 million, Crédit Mutuel Equity also engages in balance sheet investments between $1 million and $10 million. The firm emphasizes the importance of regional connections, operating through multiple offices in France and Canada, which enhances its ability to back companies within key economic areas. As a subsidiary of CM-CIC Investissement, it actively seeks board representation in its portfolio companies to foster growth and development.

A/O PropTech is a property technology venture capital firm in Europe. It combines deep real estate expertise, data science and strategic management expertise, and financial engineering with a €30bn strategic real-estate portfolio. It is stage agnostic, invests permanent capital in supporting entrepreneurs and companies shaping the future of real estate, across all segments of the ecosystem, from series A to IPO. A/O PropTech has amongst its investors some of the largest RE groups in Europe, enabling game-changing support and scale for portfolio companies across Residential (single and multi-family), commercial, retail, hospitality, and development. It has offices in London, Luxembourg and Switzerland. Plans to open Berlin offices will in 2020.

OrbiMed Advisors LLC is a healthcare-focused investment firm founded in 1989, managing approximately $5 billion in assets. The firm specializes in a range of investment strategies, including private equity, venture capital, and public equity, targeting companies across the healthcare spectrum—from startups to large multinational corporations. OrbiMed invests in various sectors within the healthcare industry, including pharmaceuticals, biotechnology, life sciences, medical devices, and health IT. The firm typically invests between $3 million and $150 million, often seeking majority stakes in its portfolio companies. With a global investment approach, OrbiMed operates from offices in New York, San Francisco, Mumbai, Herzliya, Shanghai, West Kowloon, and Luxembourg, focusing on opportunities in North America, Europe, Asia, and Israel. Its investment strategies are underpinned by fundamental analysis, encompassing investments in public equity, fixed income, and alternative markets.

Tikehau Capital is a private equity and venture capital firm established in 2004 and headquartered in Paris, France, with additional offices in Europe, North America, and Asia. The firm specializes in a diverse range of financing products, including senior secured loans, equity, senior debt, and mezzanine financing. Tikehau Capital focuses on small and middle-market corporate investments across various sectors and geographies, with a particular emphasis on Europe and Singapore. It manages long-term capital for institutional and private investors in asset classes such as credit, real estate, and private equity. The firm typically invests between €0.41 million and €70 million, seeking opportunities in early-stage, mezzanine, and turnaround investments. Tikehau Capital also operates Tikehau Investment Management, which provides expertise in credit and asset management.